These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity. Ananthan S; Saini SK; Zhou G; Hobrath JV; Padmalayam I; Zhai L; Bostwick JR; Antonio T; Reith ME; McDowell S; Cho E; McAleer L; Taylor M; Luedtke RR J Med Chem; 2014 Aug; 57(16):7042-60. PubMed ID: 25126833 [TBL] [Abstract][Full Text] [Related]
4. New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolo[2,1-b][1,3]benzothiazepine structure. Campiani G; Nacci V; Bechelli S; Ciani SM; Garofalo A; Fiorini I; Wikström H; de Boer P; Liao Y; Tepper PG; Cagnotto A; Mennini T J Med Chem; 1998 Sep; 41(20):3763-72. PubMed ID: 9748351 [TBL] [Abstract][Full Text] [Related]
5. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia. Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493 [TBL] [Abstract][Full Text] [Related]
6. Two Binding Geometries for Risperidone in Dopamine D3 Receptors: Insights on the Fast-Off Mechanism through Docking, Quantum Biochemistry, and Molecular Dynamics Simulations. Zanatta G; Della Flora Nunes G; Bezerra EM; da Costa RF; Martins A; Caetano EW; Freire VN; Gottfried C ACS Chem Neurosci; 2016 Oct; 7(10):1331-1347. PubMed ID: 27434874 [TBL] [Abstract][Full Text] [Related]
7. Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs. Millan MJ; Dekeyne A; Gobert A; Brocco M; Mannoury la Cour C; Ortuno JC; Watson D; Fone KCF Neuropharmacology; 2020 Oct; 177():108099. PubMed ID: 32525060 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles. Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766 [TBL] [Abstract][Full Text] [Related]
9. Targeting the dopamine D3 receptor: an overview of drug design strategies. Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands. Cao Y; Min C; Acharya S; Kim KM; Cheon SH Bioorg Med Chem; 2016 Jan; 24(2):191-200. PubMed ID: 26707842 [TBL] [Abstract][Full Text] [Related]
11. Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity. Bucki A; Marcinkowska M; Śniecikowska J; Więckowski K; Pawłowski M; Głuch-Lutwin M; Gryboś A; Siwek A; Pytka K; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Mierzejewski P; Kołaczkowski M J Med Chem; 2017 Sep; 60(17):7483-7501. PubMed ID: 28763213 [TBL] [Abstract][Full Text] [Related]
12. New hexahydrocarbazoles and spiro indoles, and their affinity for D2 dopamine and 5-HT2A serotonin receptors. Fernández F; García-Mera X; Rodríguez G; Urrutia A Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):1006-9. PubMed ID: 10434402 [TBL] [Abstract][Full Text] [Related]
13. Studies towards the identification of a new generation of atypical antipsychotic agents. Garzya V; Forbes IT; Gribble AD; Hadley MS; Lightfoot AP; Payne AH; Smith AB; Douglas SE; Cooper DG; Stansfield IG; Meeson M; Dodds EE; Jones DN; Wood M; Reavill C; Scorer CA; Worby A; Riley G; Eddershaw P; Ioannou C; Donati D; Hagan JJ; Ratti EA Bioorg Med Chem Lett; 2007 Jan; 17(2):400-5. PubMed ID: 17084080 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor. Austin NE; Avenell KY; Boyfield I; Branch CL; Hadley MS; Jeffrey P; Johnson CN; Macdonald GJ; Nash DJ; Riley GJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Wood MD Bioorg Med Chem Lett; 2001 Mar; 11(5):685-8. PubMed ID: 11266169 [TBL] [Abstract][Full Text] [Related]
16. Chemical puzzles in the search for new, flexible derivatives of lurasidone as antipsychotic drugs. Zaręba P; Drabczyk AK; Jaśkowska J; Satała G Bioorg Med Chem; 2020 May; 28(10):115459. PubMed ID: 32247749 [TBL] [Abstract][Full Text] [Related]
17. 1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists. Fabritius CH; Pesonen U; Messinger J; Horvath R; Salo H; Gałęzowski M; Galek M; Stefańska K; Szeremeta-Spisak J; Olszak-Płachta M; Buda A; Adamczyk J; Król M; Prusis P; Sieprawska-Lupa M; Mikulski M; Kuokkanen K; Chapman H; Obuchowicz R; Korjamo T; Jalava N; Nowak M Bioorg Med Chem Lett; 2016 Jun; 26(11):2610-5. PubMed ID: 27117428 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D Kumar V; Moritz AE; Keck TM; Bonifazi A; Ellenberger MP; Sibley CD; Free RB; Shi L; Lane JR; Sibley DR; Newman AH J Med Chem; 2017 Feb; 60(4):1478-1494. PubMed ID: 28186762 [TBL] [Abstract][Full Text] [Related]
19. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related]